55 related articles for article (PubMed ID: 2029185)
21. [Treatment with ACVP-16 for relapsed and refractory non-Hodgkin's lymphoma].
Niitsu N; Hara A; Umeda M; Shirai T
Rinsho Ketsueki; 1993 Jul; 34(7):829-34. PubMed ID: 7689661
[TBL] [Abstract][Full Text] [Related]
22. [Comparison of CHEP and CHOP chemotherapy in the management of non-Hodgkin's lymphoma].
Chen J; Wang Z
Zhonghua Zhong Liu Za Zhi; 1997 May; 19(3):209-11. PubMed ID: 10920899
[TBL] [Abstract][Full Text] [Related]
23. [THP-adriamycin-based combination chemotherapy in the treatment of non-Hodgkin's lymphoma].
Ishige K; Matsue K; Tsukuda K; Sakai C; Takagi T
Gan To Kagaku Ryoho; 1992 Oct; 19(12):2037-40. PubMed ID: 1417012
[TBL] [Abstract][Full Text] [Related]
24. [The COP-BLAM III therapy of non-Hodgkin's lymphoma].
Arai N; Hara A; Umeda M; Shirai T
Rinsho Ketsueki; 1991 Nov; 32(11):1447-52. PubMed ID: 1721937
[TBL] [Abstract][Full Text] [Related]
25. [Clinical analysis of 82 patients with non-Hodgkin's lymphoma--mainly on the evaluation of therapeutic efficacy].
Kakinoki Y; Maekawa I; Kawamura T; Miyake T; Kurosawa M; Okabe M; Kamiya K; Sasaki O
Hokkaido Igaku Zasshi; 1987 Dec; 62(6):841-50. PubMed ID: 3443427
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of delayed granulocyte colony-stimulating factor after full dose CHOP therapy in non-Hodgkin's lymphoma: a pilot study for a leukocyte count oriented regimen.
Sawada KI; Sato N; Kohno M; Hannda H; Yasukouchi T; Tanngo M; Hirayama A; Koike T
Leuk Lymphoma; 1995 Dec; 20(1-2):103-9. PubMed ID: 8750630
[TBL] [Abstract][Full Text] [Related]
27. [Clinical study on advanced non-Hodgkin's lymphoma with special reference to the results of chemotherapies with ACOP, ACOP-E and AclBEP regimen].
Nakamura S; Yoshida T; Ohtake S; Itoh K; Kobayashi K; Kanno M; Hirai J; Tachimori K; Matsuda T; Saito Y
Nihon Gan Chiryo Gakkai Shi; 1987 Jul; 22(6):1176-84. PubMed ID: 3430011
[No Abstract] [Full Text] [Related]
28. [Treatment of non-Hodgkin's lymphoma with CHOP therapy: analysis of lymphocyte subsets and interleukin 2 activity during CHOP therapy].
Suzuki Y; Yamada H; Saito Y; Nakajima H; Shinozaki T; Isono M; Chikada K; Maeno H; Sawaki S; Yamada K
Nihon Gan Chiryo Gakkai Shi; 1986 Jul; 21(6):1225-31. PubMed ID: 3491170
[No Abstract] [Full Text] [Related]
29. [The COP-BLAM therapy for non-Hodgkin's lymphoma in elderly patients].
Arai N; Hara A; Kaneko H; Shirai T
Nihon Ronen Igakkai Zasshi; 1990 May; 27(3):357-62. PubMed ID: 1699013
[TBL] [Abstract][Full Text] [Related]
30. The combined modality therapy of diffuse histology non-Hodgkin's lymphoma with cyclophosphamide, adriamycin, vincristine, prednisone (CHOP) and total body irradiation.
Weick JK; Antunez A; Kraus TA; Fabian CJ; Dixon D
Int J Radiat Oncol Biol Phys; 1983 Aug; 9(8):1205-7. PubMed ID: 6347997
[TBL] [Abstract][Full Text] [Related]
31. Failure of intensive chemotherapy in poor prognosis non-Hodgkin's lymphoma.
Matthews JR; Cooper IA; Matthews JP; Ding JC
Aust N Z J Med; 1992 Apr; 22(2):123-8. PubMed ID: 1530533
[TBL] [Abstract][Full Text] [Related]
32. [Clinical treatment of MST-16 (Sobuzoxane) for malignant lymphoma].
Nakayama S; Yabe H; Nagai K
Gan To Kagaku Ryoho; 1991 Sep; 18(12):2179-82. PubMed ID: 1888191
[No Abstract] [Full Text] [Related]
33. Intensified CHOP in non-Hodgkin's lymphoma: what we know and what we need to know.
Santoro A; Balzarotti M; Castagna L
Ann Oncol; 1999 Aug; 10(8):875-6. PubMed ID: 10509145
[No Abstract] [Full Text] [Related]
34. Vincristine infusion with CHOP-CCNU in diffuse large-cell lymphoma.
Jackson DV; Craig JB; Spurr CL; White DR; Muss HB; Cruz JM; Richards F; Powell BL
Cancer Invest; 1990; 8(1):7-12. PubMed ID: 2190676
[TBL] [Abstract][Full Text] [Related]
35. The prednisone dosage in the CHOP chemotherapy regimen for non-Hodgkin's lymphomas (NHL): is there a standard?
Moreno A; Colon-Otero G; Solberg LA
Oncologist; 2000; 5(3):238-49. PubMed ID: 10884502
[TBL] [Abstract][Full Text] [Related]
36. Combination chemotherapy with cyclophosphamide, adriamycin, vincristine and prednisone (CHOP) for non-Hodgkin's lymphomas with unfavorable histology: preliminary results.
Comella P; Abate G; Comella G; Bruni GS; Zarrilli D; Pergola M
Tumori; 1980 Dec; 66(6):749-56. PubMed ID: 7233568
[TBL] [Abstract][Full Text] [Related]
37. [Results of treatment of lymphosarcoma according to the CVP program].
Shramko AF; Kruglova GV; Poddubnaia IV
Ter Arkh; 1978; 50(7):80-4. PubMed ID: 581423
[No Abstract] [Full Text] [Related]
38. [Improvement of quality of life (QOL) and life prolongation by CPT-11 + adriamycin (ADM) therapy: report of 4 cases of non-Hodgkin's lymphoma refractory to conventional chemotherapies].
Sakai C; Saotome T; Takeshita A; Nakaseko C; Kumagai K; Takagi T
Gan To Kagaku Ryoho; 1999 Apr; 26(5):709-14. PubMed ID: 10234305
[TBL] [Abstract][Full Text] [Related]
39. Results of three polychemotherapy programs in non-Hodgkin's lymphomas.
Konopka L; Pawelski S
Haematol Blood Transfus; 1989; 32():65-70. PubMed ID: 2625264
[No Abstract] [Full Text] [Related]
40. Effect of tamoxifen on the pharmacokinetics of doxorubicin in patients with non-Hodgkin's lymphoma.
El-Yazigi A; Berry J; Ezzat A; Wahab FA
Ther Drug Monit; 1997 Dec; 19(6):632-6. PubMed ID: 9421103
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
